4//SEC Filing
Nolan Sean P. 4
Accession 0001209191-21-035165
CIK 0001806310other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 8:39 AM ET
Size
6.0 KB
Accession
0001209191-21-035165
Insider Transaction Report
Form 4
Nolan Sean P.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2021-05-20$22.35/sh+1,170$26,150→ 1,170 total
Holdings
- 1,091,101(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.04 to $22.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The securities are held by Nolan Capital, LLC (the "LLC"). The Reporting Person is the President of the LLC and has shared voting and investment power with respect to the shares held by the LLC.
Documents
Issuer
Taysha Gene Therapies, Inc.
CIK 0001806310
Entity typeother
Related Parties
1- filerCIK 0001569926
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 8:39 AM ET
- Size
- 6.0 KB